SH2B3 (LNK)mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SH2B3 (LNK)mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 161, Issue 6, Pages 811-820
Publisher
Wiley
Online
2013-04-17
DOI
10.1111/bjh.12327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
- (2012) Kathryn G. Roberts et al. CANCER CELL
- 14-3-3 regulates the LNK/JAK2 pathway in mouse hematopoietic stem and progenitor cells
- (2012) Jing Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Possible new LNK mutations in myeloproliferative neoplasms
- (2011) Jung-Sook Ha et al. AMERICAN JOURNAL OF HEMATOLOGY
- A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis
- (2011) Mary Frances McMullin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling
- (2011) Saskia Gueller et al. EXPERIMENTAL HEMATOLOGY
- Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations
- (2011) T L Lasho et al. LEUKEMIA
- LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation
- (2011) C. Hurtado et al. LEUKEMIA RESEARCH
- Octa-Arginine Mediated Delivery of Wild-Type Lnk Protein Inhibits TPO-Induced M-MOK Megakaryoblastic Leukemic Cell Growth by Promoting Apoptosis
- (2011) Chung Yeng Looi et al. PLoS One
- Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms
- (2011) N. C. P. Cross Hematology-American Society of Hematology Education Program
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- BCR-ABL but Not JAK2 V617F Inhibits Erythropoiesis through the Ras Signal by Inducing p21CIP1/WAF1
- (2010) Masahiro Tokunaga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lnk constrains myeloproliferative diseases in mice
- (2010) Alexey Bersenev et al. JOURNAL OF CLINICAL INVESTIGATION
- Adaptor protein Lnk inhibits c-Fms-mediated macrophage function
- (2010) Saskia Gueller et al. JOURNAL OF LEUKOCYTE BIOLOGY
- LNK mutation studies in blast-phase myeloproliferative neoplasms and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
- (2010) A Pardanani et al. LEUKEMIA
- Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
- (2009) Sigal Gery et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
- (2009) Masashi Sanada et al. NATURE
- Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction
- (2009) Daniel F Gudbjartsson et al. NATURE GENETICS
- Adaptor protein Lnk associates with Tyr568in c-Kit
- (2008) Saskia Gueller et al. BIOCHEMICAL JOURNAL
- Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells
- (2008) C. Simon et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started